Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
18th June 2014
Pfizer Inc. (NYSE:PFE) has announced the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass.
The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.
Read more at source article www.worldpharmanews.com